Gibraltar Laboratories, Inc. | Daniel Prince, PhD identification of cber-regulated generic drug facility
- Manufacturer
- Gibraltar Laboratories, Inc. | Daniel Prince, PhD
- Effective date
- 2013-05-20
- Label type
- Identification of CBER-regulated generic drug facility
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-06-01 02:47:43
Label at a glance#
Source Document#
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.